Streptococcal emm types in hawaii: A region with high incidence of acute rheumatic fever

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 13-16

  Erdem, Guliz ^a   Mizumoto, Carla ^a   Esaki, David ^a   Abe, Lucienne ^a   Reddy, Venu ^a   Effler, Paul V ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b HAWAII STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

acute rheumatic fever; emm sequencing; epidemiology; streptococcal vaccine; Streptococcus pyogenes

Indexed keywords

STREPTOCOCCUS VACCINE;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL FEATURE; EMM GENE; GENE SEQUENCE; HUMAN; INCIDENCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; THROAT CULTURE; UNITED STATES;

ACUTE DISEASE; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; HAWAII; HUMANS; PHARYNX; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 66149102324     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31818128ce     Document Type: Article

References (33)

1. Bisno A. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325:783-793.
2. Chun LT, Reddy DV, Yim GK, et al. Acute rheumatic fever in Hawaii: 1966 to 1988. Hawaii Med J. 1992;51:206-211.
3. Erdem G, Ford J, Kanenaka RY, et al. Molecular epidemiologic comparison of two group A streptococcal necrotizing fasciitis community clusters in Hawaii. Clin Infect Dis. 2005;40:1851-1854.
4. Erdem G, Abe L, Kanenaka RY, et al. Characterization of a community cluster of group a streptococcal invasive disease in Maui, Hawaii. Pediatr Infect Dis J. 2004;23:677-679.
5. Erdem G, Reddy DV, Yamaga K, et al. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis. 2007;45:e20-e24.
6. Yim H. Rheumatic fever in Hawaii. Am J Dis Child. 1962;103:715-717.
7. Kurahara D, Tokuda A, Grandinetti A, et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J Rheumatol. 2002;29:379-383.
8. Beall B, Facklam R, Hoenes T, et al. Application of emm gene sequencing and T antigen serology for typing group A streptococcal systemic isolates. In: Horaud T, Bouvet A, Leclerq R, et al, eds. Streptococci and the Host. New York, NY: Plenum Press; 1997:21-27.
9. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989;2:285-314.0
10. Johnson DR, Kaplan EL, Sramek J. Laboratory Diagnosis of Group A Streptococcal Infections. Geneva: World Health Organization; 1996.
11. Johnson DR, Kaplan EL, Vangheem A, et al. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M protein and emmgene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol. 2006;55:157-164.
12. Centers for Disease Control and Prevention (CDC). Available at: http:// www.cdc.gov/ncidod/biotech/strep/strepindex.htm. Accessed November 26, 2007.
13. Hoe NP, Fullerton KE, Liu M, et al. Molecular genetic analysis of 675 group A streptococcus isolates collected in a carrier study at Lackland Air Force Base, San Antonio, Texas. J Infect Dis. 2003;188:818-827.
14. Li Z, Sakota V, Jackson D, et al. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis. 2003;188:1587-1592.
15. O'Brien KL, Levine OS, Schwartz B. The changing epidemiology of group A streptococcus infections. Semin Pediatr Infect Dis. 1997;8:10-16.
16. Erdem G, Ford J, Abe L, et al. Erythromycin resistant group A streptococcal isolates from Oahu, Hawaii. J Clin Microbiol. 2005;43:2497-2499.
17. Shulman S, Stollerman G, Beall B, et al. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis. 2006;42:441-447.
18. Centers for Disease Control and Prevention (CDC). Available at: http:// www.cdc.gov/ncidod/biotech/&files/emmtype-freq2003-04.ppt. Accessed November 26, 2007.
19. Shulman ST, Tanz RR, Kabat W, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis. 2004; 39:325-332.0
20. Hu MC, Walls MA, Stroop S, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70:2171-2177.
21. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis. 1992;166:374-382.
22. Anthony BF, Kaplan EL, Wannamaker LW, et al. The dynamics of the streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol. 1976; 104:652-666.
23. Bessen DE, Carapetis JR, Beall B, et al. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis. 2000;182:1109-1116.
24. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother. 2000;45:3-12.
25. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
26. Tewodros W, Muhe L, Daniel E, et al. A one year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect. 1992;109:211-225.7
27. Dey N, McMillan DJ, Yarwood PJ, et al. High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis. 2005;40:46-51.
28. Beall B, Facklam R, Hoenes T, et al. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol. 1997;35:1231-1235.
29. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;5:547-554.0
30. Centers for Disease Control and Prevention (CDC). Available at: http://www. cdc.gov/ncidod/dbmd/abcs/survreports.htm. Accessed November 26, 2007.
31. Kotloff KL, Corretti M, Palmer K. Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004;292:709-715.
32. Lee GM, Wessels MR. Changing epidemiology of acute rheumatic fever in the United States. Clin Infect Dis. 2006;42:448-450.
33. McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005;41:1114-1122.